4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-24-002173
EXEC. VP AND CLO sold 794 shares at $27.25 ($21,637)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boulding Mark Elliott EXEC. VP AND CLO | 2024-01-30 | Sale 10b5-1 | −794 | $27.25 | $21,637 | 71,189 | D |
| Open-market sales · 794 sh · avg $27.25 · $21,637 | |||||||
Loading xslF345X05/form4-02012024_090230.xml…